Drug Shortage Report for SANDOZ GLICLAZIDE MR
Report ID | 230199 |
Drug Identification Number | 02461323 |
Brand name | SANDOZ GLICLAZIDE MR |
Common or Proper name | GLICLAZIDE MR |
Company Name | SANDOZ CANADA INCORPORATED |
Market Status | MARKETED |
Active Ingredient(s) | GLICLAZIDE |
Strength(s) | 30MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 60MRT |
ATC code | A10BB |
ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-06-12 |
Estimated end date | |
Actual end date | 2024-12-06 |
Shortage status | Resolved |
Updated date | 2024-12-07 |
Company comments | Discontinued |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-12-07 | English | Compare |
v6 | 2024-12-06 | French | Compare |
v5 | 2024-12-06 | English | Compare |
v4 | 2024-06-13 | English | Compare |
v3 | 2024-06-12 | French | Compare |
v2 | 2024-06-12 | English | Compare |
v1 | 2024-06-12 | English | Compare |
Showing 1 to 7 of 7